Pathologic significance of a novel oncoprotein in thyroid cancer progression.

Anthony A FirekMia C PerezAmber GondaLi LeiIqbal MunirAlfred A SimentalFrances E CarrBenjamin J BecerraMarino De LeonSalma Khan

Published in: Head & neck (2017)

Enigma may serve as an oncoprotein marker, identifying benign from malignant thyroid tissue on FNA. Enigma may have a role in carcinogenesis of thyroid cancer independent of tissue calcification, possibly in relation to interaction with BMP-1.

Keyphrases

neoadjuvant chemotherapy
mesenchymal stem cells
chronic kidney disease
squamous cell carcinoma
radiation therapy
locally advanced
bone marrow